{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:19:28Z","timestamp":1783059568965,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"DOI":"10.7759\/cureus.111969","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:31:31Z","timestamp":1783056691000},"source":"Crossref","is-referenced-by-count":0,"title":["Fosfomycin Resistance in Escherichia coli: Mechanisms, Trends, and Clinical Challenges"],"prefix":"10.7759","author":[{"given":"Gaurav N","family":"Patkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka M","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Scoping Report on Antimicrobial Resistance in India","author":"Gandra S","year":"2017","unstructured":"Gandra S, Joshi J, Trett A, Lamkang AS, Laxminarayan R. Scoping Report on Antimicrobial Resistance in India. Center for Disease Dynamics, Economics & Policy, Washington, DC; 2017."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_331_18","article-title":"Antimicrobial resistance in the environment: the Indian scenario","volume":"149","author":"Taneja N","year":"2019","unstructured":"Taneja N, Sharma M. Antimicrobial resistance in the environment: the Indian scenario. Indian J Med Res. 2019, 149:119-28. 10.4103\/ijmr.IJMR_331_18","journal-title":"Indian J Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8229.108180","article-title":"Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India","volume":"20","author":"Dash M","year":"2013","unstructured":"Dash M, Padhi S, Mohanty I, Panda P, Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India. J Family Community Med. 2013, 20:20-6. 10.4103\/2230-8229.108180","journal-title":"J Family Community Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2727.119849","article-title":"Determination of extended-spectrum \u03b2-lactamases and AmpC production in uropathogenic isolates of Escherichia coli and susceptibility to fosfomycin","volume":"5","author":"Gupta V","year":"2013","unstructured":"Gupta V, Rani H, Singla N, Kaistha N, Chander J. Determination of extended-spectrum \u03b2-lactamases and AmpC production in uropathogenic isolates of Escherichia coli and susceptibility to fosfomycin. J Lab Physicians. 2013, 5:90-3. 10.4103\/0974-2727.119849","journal-title":"J Lab Physicians"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2016.01.010","article-title":"Fosfomycin: resurgence of an old companion","volume":"22","author":"Sastry S","year":"2016","unstructured":"Sastry S, Doi Y. Fosfomycin: resurgence of an old companion. J Infect Chemother. 2016, 22:273-80. 10.1016\/j.jiac.2016.01.010","journal-title":"J Infect Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin, a new antibiotic produced by strains of streptomyces","volume":"166","author":"Hendlin D","year":"1969","unstructured":"Hendlin D, Stapley EO, Jackson M, et al.. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science. 1969, 166:122-3. 10.1126\/science.166.3901.122","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025262","article-title":"Fosfomycin: mechanism and resistance","volume":"7","author":"Silver LL","year":"2017","unstructured":"Silver LL. Fosfomycin: mechanism and resistance. Cold Spring Harb Perspect Med. 2017, 7:10.1101\/cshperspect.a025262","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos AS","year":"2011","unstructured":"Michalopoulos AS, Livaditis IG, Gougoutas V. The revival of fosfomycin. Int J Infect Dis. 2011, 15:e732-9. 10.1016\/j.ijid.2011.07.007","journal-title":"Int J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas ME","year":"2016","unstructured":"Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ. Fosfomycin. Clin Microbiol Rev. 2016, 29:321-47. 10.1128\/CMR.00068-15","journal-title":"Clin Microbiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics2020217","article-title":"Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance","volume":"2","author":"Casta\u00f1eda-Garc\u00eda A","year":"2013","unstructured":"Casta\u00f1eda-Garc\u00eda A, Bl\u00e1zquez J, Rodr\u00edguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics (Basel). 2013, 2:217-36. 10.3390\/antibiotics2020217","journal-title":"Antibiotics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro818","article-title":"Pathogenic Escherichia coli","volume":"2","author":"Kaper JB","year":"2004","unstructured":"Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004, 2:123-40. 10.1038\/nrmicro818","journal-title":"Nat Rev Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles AL","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015, 13:269-84. 10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout JD","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008, 8:159-66. 10.1016\/S1473-3099(08)70041-0","journal-title":"Lancet Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine MH","year":"2014","unstructured":"Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014, 27:543-74. 10.1128\/CMR.00125-13","journal-title":"Clin Microbiol Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00749-17","article-title":"Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene","volume":"8","author":"Ito R","year":"2017","unstructured":"Ito R, Mustapha MM, Tomich AD, et al.. Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene. mBio. 2017, 8:10.1128\/mBio.00749-17","journal-title":"mBio"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1178547","article-title":"Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat","volume":"13","author":"Mattioni Marchetti V","year":"2023","unstructured":"Mattioni Marchetti V, Hrabak J, Bitar I. Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat. Front Cell Infect Microbiol. 2023, 13:1178547. 10.3389\/fcimb.2023.1178547","journal-title":"Front Cell Infect Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks465","article-title":"Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin","volume":"68","author":"Hou J","year":"2013","unstructured":"Hou J, Yang X, Zeng Z, Lv L, Yang T, Lin D, Liu JH. Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin. J Antimicrob Chemother. 2013, 68:766-70. 10.1093\/jac\/dks465","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas ME","year":"2010","unstructured":"Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010, 10:43-50. 10.1016\/S1473-3099(09)70325-1","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnu018","article-title":"Coexistence of SFO-1 and NDM-1 \u03b2-lactamase genes and fosfomycin resistance gene fosA3 in an Escherichia coli clinical isolate","volume":"362","author":"Zhao JY","year":"2015","unstructured":"Zhao JY, Zhu YQ, Li YN, et al.. Coexistence of SFO-1 and NDM-1 \u03b2-lactamase genes and fosfomycin resistance gene fosA3 in an Escherichia coli clinical isolate. FEMS Microbiol Lett. 2015, 362:1-7. 10.1093\/femsle\/fnu018","journal-title":"FEMS Microbiol Lett"},{"key":"ref20","article-title":"Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M10","year":"2023","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M10. Clinical & Laboratory Standards Institute, 2023."},{"key":"ref21","article-title":"Role of Fosfomycin activity on ESBL producing E.coli and Klebsiella pneumoniae isolated in clinical samples at a tertiary care hospital, Sudha Medical College, Jagpura, Kota","volume":"13","author":"Soni G","year":"2024","unstructured":"Soni G, Ahmed R, Vijay A, et al.. Role of Fosfomycin activity on ESBL producing E.coli and Klebsiella pneumoniae isolated in clinical samples at a tertiary care hospital, Sudha Medical College, Jagpura, Kota. Front Health Inform. 2024, 13:450-60.","journal-title":"Front Health Inform"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01519-08","article-title":"Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum \u03b2-lactamases","volume":"53","author":"Prakash V","year":"2009","unstructured":"Prakash V, Lewis JS 2nd, Herrera ML, Wickes BL, Jorgensen JH. Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother. 2009, 53:1278-80. 10.1128\/AAC.01519-08","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.08.026","article-title":"What is antimicrobial stewardship?","volume":"23","author":"Dyar OJ","year":"2017","unstructured":"Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship?. Clin Microbiol Infect. 2017, 23:793-8. 10.1016\/j.cmi.2017.08.026","journal-title":"Clin Microbiol Infect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/503155-fosfomycin-resistance-in-escherichia-coli-mechanisms-trends-and-clinical-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:31:32Z","timestamp":1783056692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/503155-fosfomycin-resistance-in-escherichia-coli-mechanisms-trends-and-clinical-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.111969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}